Alsteni's solution is a minimally invasive, fully-reversible Class II medical device that delivers nutrients directly to the upper intestine, mimicking the beneficial effects of both gastric bypass surgery and GLP-1 drugs. By targeting the same physiological pathways that make these treatments effective for weight loss, but without requiring permanent surgical changes or ongoing medication, it offers a new therapeutic option that can be easily initiated or discontinued based on patient needs.
Is this your company?
Something looks off?